Company Overview and News

29
ESPN streaming service surpasses one million subscribers

4h thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CBS FB CBS.A GOOGL TWTR NFLX GOOG CPV CBS.WD DIS

1
An Epic Proposal, Greek-American Betty White Steal Emmys Show

22h thenationalherald
Betty White, left, speaks at the 70th Primetime Emmy Awards on Monday, Sept. 17, 2018, at the Microsoft Theater in Los Angeles. Looking on from right are Alec Baldwin and Kate McKinnon. (Photo by Chris Pizzello/Invision/AP)
CBS CBS.A CPV CBS.WD

20
Canada’s Tilray most valuable cannabis company after stock soars

2018-09-19 thestar - 2
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: www.TorontoStarReprints.com
CBS STZ.B HSYFB CBS.A AAL STZ CBS.WD CGC TLRY WEED CPV BEAV CLX HSY

1
Julie Chen bids farewell to 'The Talk' after Moonves allegations

2018-09-18 reuters
NEW YORK (Reuters) - Julie Chen, the wife of former CBS Corp CBS CBS.A CPV CBS.WD

1
CBS: A Lot Has Changed For Investors

2018-09-16 seekingalpha
CBS's stock has been stagnant/declining recently due to the bitter dispute over whether to merge with Viacom or not.
CBS CBS.A VIAB CPV CBS.WD

1
Steve Bannon: Time's Up is most powerful political movement

2018-09-15 nzherald.co.nz
WASHINGTON (AP) — President Donald Trump's former chief strategist says he's surprised the #MeToo movement hasn't had more impact on corporate America.
CBS CBS.A CPV CBS.WD

1
The Ratings Game: CBS board and management shake-up is a clear benefit for shareholders, analyst says

2018-09-13 marketwatch
CBS is no longer ‘uninvestable’ after board settles suit with National Amusements, Moonves out as CEO, board refresh
CBS CBS.A CPV CBS.WD

2
PRESS DIGEST-New York Times business news - Sept 13

2018-09-13 reuters
Sept 13 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.
CBS CBS.A AAPL NYTAB CPV CBS.WD

1
Coverup was last straw in Moonves' ouster from CBS: report

2018-09-13 marketwatch
The last straw that led to the ouster of CBS Corp. CBS, -0.47% Chief Executive Les Moonves was not the new claims of sexual assault and harassment in a New Yorker article Sunday, but revelations in August that he was being blackmailed by one of his alleged victims and was trying to get her a job to secure her silence, the New York Times reported late Wednesday. Moonves still had strong support from some CBS board members after the first allegations against him were published by the New Yorker in July, the Times said.
CBS CBS.A NYTAB CPV CBS.WD

1
Key Words: ‘Designing Women’ creator details how Les Moonves derailed her career

2018-09-12 marketwatch
Those are the words of Linda Bloodworth Thomason, a onetime TV hitmaker for CBS Corp. CBS, -0.47% , in a scathing guest column published Wednesday by the Hollywood Reporter.
CBS CBS.A CPV CBS.WD

1
The Wall Street Journal: Bob Woodward’s new Trump book ‘Fear’ posts huge sales

2018-09-12 marketwatch
Reader interest in the inner workings of the Trump White House is showing no signs of fading.
CBS NOBGF CBS.A N21 NOBGY CPV CBS.WD

89
10 Super Safe Growth Stocks to Buy for Long-Lasting Dividends

2018-09-12 investorplace
Whenever the stock market marches higher, it pushes the prices of many companies higher along with it. But as investors bid up good and bad businesses alike, that can make it hard to discern which companies are the best dividend stocks for long-term investors.
LOW TXN ADP VZA HON AMT AAPL CCI CBS HON TMUSP CBS.A TMUS BDX COST CBS.WD MDT HRL S T ADPVV VZ CPV

37
Viacom Stock Isn’t Cheap Enough on Its Own

2018-09-12 investorplace
Viacom (NASDAQ:VIA,VIAB) unquestionably is cheap. The B shares of Viacom stock trade at barely seven times 2018 consensus EPS estimates. VIAB stock also has an attractive 2.76% dividend yield.
CBS VIA AMZN AMCX CBS.A NFLX CPV CBS.WD BEAV

1
60 Minutes Jeff Fager leaving CBS after reports of inappropriate behavior

2018-09-12 reuters
(Reuters) - The executive producer of the CBS television program “60 Minutes,” Jeff Fager, is leaving CBS News, according to a company memo on Wednesday, amid reports of inappropriate behavior.
CBS CBS.A CPV CBS.WD

1
'60 Minutes' chief Fager out at CBS

2018-09-12 nzherald.co.nz
NEW YORK (AP) — CBS "60 Minutes" executive producer Jeff Fager says he's leaving the company, after being named in recent stories that accused him of fostering an abusive workplace.
CBS CBS.A CPV CBS.WD

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

CUSIP: 124857103